➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Baxter
AstraZeneca
McKinsey
Mallinckrodt

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Seattle Genetics Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for SEATTLE GENETICS, and when can generic versions of SEATTLE GENETICS drugs launch?

SEATTLE GENETICS has one approved drug.

There are four US patents protecting SEATTLE GENETICS drugs.

There are one hundred and nine patent family members on SEATTLE GENETICS drugs in thirty-six countries.

Summary for Seattle Genetics
International Patents:109
US Patents:4
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Seattle Genetics

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Seattle Genetics TUKYSA tucatinib TABLET;ORAL 213411-002 Apr 17, 2020 RX Yes Yes 9,693,989   Start Trial Y   Start Trial
Seattle Genetics TUKYSA tucatinib TABLET;ORAL 213411-002 Apr 17, 2020 RX Yes Yes 7,452,895   Start Trial Y Y   Start Trial
Seattle Genetics TUKYSA tucatinib TABLET;ORAL 213411-001 Apr 17, 2020 RX Yes No 7,452,895   Start Trial Y Y   Start Trial
Seattle Genetics TUKYSA tucatinib TABLET;ORAL 213411-001 Apr 17, 2020 RX Yes No 9,693,989   Start Trial Y   Start Trial
Seattle Genetics TUKYSA tucatinib TABLET;ORAL 213411-002 Apr 17, 2020 RX Yes Yes 9,457,093   Start Trial Y   Start Trial
Seattle Genetics TUKYSA tucatinib TABLET;ORAL 213411-001 Apr 17, 2020 RX Yes No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Baxter
Dow
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.